BCL9L anticorps (AA 525-575)

N° du produit ABIN7450025

Détail du produit anti-BCL9L anticorps

Antigène: BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))

Épitope: AA 525-575

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCL9L est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Fonction: Rabbit anti-BCL9L Antibody, Affinity Purified

Purification: Affinity Purified

Immunogène: between AA 525 and 575

Isotype: IgG

Information d'application

Indications d'application:

IP: 2 - 10 μg/mg lysate

WB: 1:2,000 - 1:10,000

Restrictions: For Research Use only

Stockage

Concentration: 1000 μg/mL

Buffer: Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Date de péremption: 12 months

Détails sur BCL9L

Antigène: BCL9L (B-Cell CLL/lymphoma 9-Like (BCL9L))

Autre désignation: BCL9L (BCL9L Produits)

Synonymes: anticorps BCL9-2, anticorps DLNB11, anticorps B9L, anticorps BC003321, anticorps bcl9-2, anticorps BCL9L, anticorps B-cell CLL/lymphoma 9 like, anticorps B cell CLL/lymphoma 9-like, anticorps B-cell CLL/lymphoma 9-like, anticorps BCL9L, anticorps Bcl9l, anticorps bcl9l

Sujet: Background: B-cell lymphoma 9-like protein (BCL9L) is a transcriptional regulator that acts as an activator. BCL9L promotes beta-catenin transcriptional activity and plays a role in tumorigenesis [taken from the Universal Protein Resource (UniProt) Q86UU0].

ID gène: 283149

NCBI Accession: NP_872363

UniProt: Q86UU0

Pathways: Stem Cell Maintenance